Expanding noninvasive prenatal testing to include microdeletions and segmental aneuploidy: Cause for concern?

Genetics in Medicine

Volumn 18, Issue 3, 2016, Pages 275-276

  Sahoo, Trilochan ^a   Hovanes, Karine ^a   Strecker, Michelle N ^a   Dzidic, Natasa ^a   Commander, Sara ^a   Travis, Mary K ^a  

^a Combimatrix Molecular Diagnostics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CHROMOSOME 13; CHROMOSOME DELETION; DNA MICROARRAY; FETUS; FETUS DISEASE; HOMOZYGOSITY; HUMAN; KARYOTYPING; LETTER; PREDICTIVE VALUE; PRENATAL SCREENING; SEGMENTAL ANEUPLOIDY; BLOOD; FEMALE; GENETIC SCREENING; PREGNANCY; PRENATAL DIAGNOSIS;

DNA;

CHROMOSOME DELETION; DNA; FEMALE; GENETIC TESTING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84959267420     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.196     Document Type: Letter

References (3)

1. Cheung SW, Patel A, Leung TY. Accurate description of DNA-based noninvasive prenatal screening. N Engl J Med 2015;372:1675-1677.
2. Wang JC, Sahoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: A study of 109 consecutive cases. Genet Med 2015;17:234-236.
3. Yatsenko SA, Peters DG, Saller DN, Chu T, Clemens M, Rajkovic A. Maternal cellfree DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. Genet Med 2015;17:836-838.